Leukemia and MDS Translational Research Disease Group

Understanding the genetic alterations that lead to brain cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of Leukemia and MDS that lead to new, innovative prevention and targeted therapy options for our patients.

Connect with Fox Chase